Mixed Connective Tissue Disease: Clinical Trials

3 trials for Mixed Connective Tissue Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1
Phase 33Completed 2, Terminated 1

Follow Mixed Connective Tissue Disease: new trials by email Literature Review of Mixed Connective Tissue Disease trials Research Report on Mixed Connective Tissue Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Rituximab, Cyclophosphamide - Interstitial Lung Disease, Scleroderma
Phase 2 / Phase 3CompletedRoyal Brompton & Harefield NHS Foundation Trust1042014-11-012021-10-07
A Clinical Trial for CTD-ILD Treatment
N-Acetylcysteine - Interstitial Lung Disease, Connective Tissue Disease
Phase 2 / Phase 3TerminatedUniversity of Michigan52011-12-012017-04-06
Alendronate Osteoporosis Study
Alendronate - Glucocorticoid-Associated Osteopenia and Osteoporosis
Phase 2 / Phase 3CompletedBoston Children's Hospital202003-03-012017-04-11

Narrower conditions

Dermatomyositis (3)  ·  Connective Tissue Diseases (2)  ·  Lung Diseases, Interstitial (2)  ·  Polymyositis (2)  ·  Scleroderma, Diffuse (2)  ·  Arthritis, Juvenile (1)  ·  Arthritis, Rheumatoid (1)  ·  Crohn Disease (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Myositis (1)  ·  Osteoporosis (1)  ·  Pulmonary Fibrosis (1)  ·  Sjogren's Syndrome (1)  ·  Vasculitis (1)

Broader conditions

Muscular Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Nervous System Diseases (3)  ·  Neuromuscular Diseases (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Arthritis (2)  ·  Autoimmune Diseases (2)  ·  Immune System Diseases (2)  ·  Joint Diseases (2)  ·  Lung Diseases (2)  ·  Myositis (2)  ·  Respiratory Tract Diseases (2)  ·  Rheumatic Diseases (2)  ·  Scleroderma, Systemic (2)

Interventions

Acetylcysteine (1)  ·  Alendronate (1)  ·  Cyclophosphamide (1)  ·  Rituximab (1)

Sponsors

Boston Children's Hospital (1)  ·  Royal Brompton & Harefield NHS Foundation Trust (1)  ·  University of Michigan (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

Catherine Gordon, MD (1)  ·  Toby M Maher, MD PhD (1)

Results publications

PMID 28619061, PMID 36375479